Title:
USE OF AN ACTIVE SUBSTANCE IN THE TREATMENT OF TELANGIECTATIC MELASMA
Document Type and Number:
WIPO Patent Application WO/2018/000067
Kind Code:
A1
Abstract:
The present invention generally belongs to the technological field of the pharmaceutical industry and relates more specifically to one or more second use compositions for the treatment of melasma, in particular in cases of melasma identified as telangiectatic melasma. The present invention relates to the use of substances belonging to the group of alpha-adrenergic receptor agonists in different, variable concentrations for the treatment of human skin melasma disorders. The present invention further provides pharmaceutical compositions which can be optionally associated with other compounds or treatment methods for use in the treatment of telangiectatic melasma.
Inventors:
HEXSEL DORIS MARIA (BR)
Application Number:
PCT/BR2017/050167
Publication Date:
January 04, 2018
Filing Date:
June 28, 2017
Export Citation:
Assignee:
HEXSEL DORIS MARIA (BR)
International Classes:
A61P17/00; A61K31/498
Domestic Patent References:
| WO2011117378A2 | 2011-09-29 |
Foreign References:
| US20100021402A1 | 2010-01-28 |
Other References:
See also references of EP 3476393A4
Attorney, Agent or Firm:
BARCELLOS, Milton Lucídio Leão (BR)
Download PDF:
Previous Patent: IMPROVEMENT TO CAKE PACKAGING AND METHOD FOR SECURING A CAKE IN THE PACKAGING
Next Patent: HAIR CARE FORMULATION FROM CONCENTRATE
Next Patent: HAIR CARE FORMULATION FROM CONCENTRATE